-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

801. Gene Therapies: Poster III

Symposia: Gene Therapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Akshay Sharma, MBBS1, Jane S Hankins, MD, MS1, Jaap Jan Boelens, MD2, Maria Cancio2*, Radhika Peddinti, MD, MBBS3, Lawrence Rispoli, BA4*, Sarah Sloan5*, Sarah DiDominick Costa4*, Sharon Peled4*, Andrea Wiethoff4* and James LaBelle, MD, PhD3

1St. Jude Children's Research Hospital, Memphis, TN
2Memorial Sloan Kettering Cancer Center, New York, NY
3University of Chicago Medicine, Chicago
4Novartis Biomedical Research, Cambridge, MA
5Novartis Pharma AG, Basel, Switzerland

Haydar Frangoul, MD1, Franco Locatelli, MD2, Akshay Sharma, MBBS3, Monica Bhatia, MD4*, Markus Y Mapara, MD5, Robert I. Liem, MD6, Donna Wall, MD7, Lyndsay Molinari, MD8, Laurence Dedeken, MD9, Kevin H.M. Kuo, MD, MSc, FRCPC10, Paul Telfer, MD, FRCP11*, Ami J. Shah, MD12, Marina Cavazzana, MD, PhD13, Selim Corbacioglu, MD, PhD14, Michael J. Eckrich15, Damiano Rondelli, MD16*, Roland Meisel, MD17*, Stephan Lobitz, MD, MSc18*, Mariane De Montalembert, MD, PhD13, Martin H. Steinberg, MD19, Mark C. Walters, MD20*, Laura Bower, MD21*, Suzan Imren, MD21*, Tina Liu, PhD21*, Weiyu Zhou, PhD21*, William Hobbs, MD, PhD21 and Stephan A. Grupp, MD, PhD22

1Sarah Cannon Research Institute at the Children's Hospital at TriStar Centennial, Nashville, TN
2IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart, Rome, Italy
3Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
4Department of Pediatrics, Columbia University Irving Medical Center, New York – Presbyterian-Morgan Stanley Children’s Hospital, New York, NY
5Department of Medicine, Division of Hematology & Oncology, Columbia University, New York
6Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
7The Hospital for Sick Children/University of Toronto, Toronto, Canada
8Sarah Cannon Pediatric Transplant and Cellular Therapy Program at Methodist Children’s Hospital, San Antonio, TX
9Hôpital Universitaire des Enfants Reine Fabiola, Brussels, BEL
10Division of Hematology, University of Toronto, Toronto, ON, Canada
11Royal London Hospital, Barts Health NHS Trust, London, United Kingdom
12Stanford University, Palo Alto, CA
13Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris, Paris, France
14University of Regensburg, Regensburg, Germany
15Atrium Health in Charlotte, Charlotte, NC
16Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
17Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
18Pädiatrische Hämatologie und Onkologie, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
19Boston University Chobanian & Avedisian School of Medicine, Boston, MA
20UCSF Benioff Children’s Hospital Oakland, Oakland, CA
21Vertex Pharmaceuticals Incorporated, Boston, MA
22Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Rabi Hanna, MD1, Haydar Frangoul, MD2, Christopher McKinney, MD3, Luis Pineiro, MD4*, Markus Mapara, MD, PhD5*, Jignesh Dalal, MD6*, Hemalatha Rangarajan, MD7, Harold Atkins, MD8*, Kai-Hsin Chang, PhD9, Baisong Mei, MD, PhD9*, Olubunmi Afonja, MD, MBA9* and Mark C. Walters, MD10*

1Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH
2Sarah Cannon Center for Blood Cancer at the Children's Hospital at TriStar Centennial, Nashville, TN
3Children’s Hospital of Colorado, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO
4Blood and Marrow Transplant Program and Marrow Processing Laboratory, Baylor University Medical Center, Dallas, TX
5Bone Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York City, NY
6Rainbow Babies & Children’s Hospital, Cleveland, OH
7Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH
8Transplant and Cell Therapy Program, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada
9Editas Medicine, Inc., Cambridge, MA
10School of Medicine, University of California, San Francisco and Benioff Children’s Hospital, Oakland, CA

Britney Hernandez, BS1*, Ashwin P. Patel, MD, PhD, MPH2, Erica N Evans1*, Jordan Zgodny, BA1*, Stephen Gottschalk, MD3, Brandon M Triplett, MD3*, Serena De Vita, MD, PhD4*, Kirby Wallace, PhD5*, David C Shyr, MD6, Elizabeth O Stenger, MD, MSc7, Suhag Parikh, MD7*, Akshay Sharma, MBBS8 and Vivien Sheehan, MD, PhD9

1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
2Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
3Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
4Novartis Biomedical Research, Cambridge, MA
5Kamau Therapeutics, South San Francisco, CA
6Department of Pediatrics/ Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
7Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
8Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
9Emory University School of Medicine, Atlanta, GA

Priya S. Chockalingam, PhD1*, Ling Lin, PhD1*, Guo Chen, PhD1*, Alex C. Minella, MD1, Yinzhong Chen, PhD1*, Vivien Sheehan, MD, PhD2, Nan Zhang, MD, PhD3*, Myriam Armant, PhD4*, Aliya U. Zaidi, PhD5*, Robert Goodrich, BSc6*, Patrick C. Hines, MD, PhD5, Sunita Goyal, MD1* and Amy Simon, MD1*

1Beam Therapeutics Inc., Cambridge, MA
2Emory University School of Medicine, Atlanta, GA
3Frontage Laboratories, Inc - Exton, PA, Exton, PA
4Translab, Boston Children's Hospital, Boston, MA
5Functional Fluidics Inc, Detroit, MI
6Functional Fluidics Inc., Detroit, MI

Sandra Santos1*, Tara M. Robinson, MD, PhD2 and David Trueman3*

1BioMarin UK Ltd., London, United Kingdom
2BioMarin Pharmaceutical Inc., Novato, CA
3Source Health Economics, London, United Kingdom

Li Wang, MD1*, Hui Xu, PhD2, Junbin Liang2*, Yaoyun Li3*, Lin Cheng2*, Ying Luo2*, Liancheng Huang2*, Lei Shi2*, Lihong Zeng4*, Rongrong Luo3*, Bin Xiao3*, Meiping Liu3*, Liping Huang3*, Zhendong Xiao5*, Xinhua Zhang, MD1* and Junjiu Huang, PhD6*

1923rd Hospital of the People's Liberation Army, Nanning, Guangxi, China
2Reforgene Medicine, Guangzhou, China
3Department of Pediatrics, 923rd Hospital of the People's Liberation Army, Nanning, China
4Department of Blood Transfusion, 923rd Hospital of the People's Liberation Army, Nanning, China
5Biotherapy Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
6School of Life Sciences, Sun Yat-sen University, Guangzhou, China

Rongrong Liu, MD1*, Li Wang2*, Hui Xu, PhD3, Jianpei Fang4*, Sixi Liu5*, Xiaolin Yin6*, Junbin Liang3*, Xinyu Li4*, Yue Li5*, Gaohui Yang1*, Yaoyun Li2*, Yali Zhou6*, Lei Shi3*, Yongrong Lai, MD1*, Junjiu Huang, PhD7* and Xinhua Zhang, MD8*

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2Department of Pediatrics, 923rd Hospital of the People's Liberation Army, Nanning, China
3Reforgene Medicine, Guangzhou, China
4Department of Pediatrics, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China
5Department of Pediatrics, Shenzhen Children’s Hospital, Shenzhen, China
6Department of Hematology, 923rd Hospital of the People's Liberation Army, Nanning, China
7School of Life Sciences, Sun Yat-sen University, Guangzhou, China
8923rd Hospital of the People's Liberation Army, Nanning, Guangxi, China

Ruonan Li1,2,3*, Zhen Gao1,2,3*, Yucan Shen1,2,3*, Lele Zhang1,2,3*, Ke Huang1,2,3*, Hong Pan1,3,4*, Weiwang Li1,2,5*, Linzhu Tian1,2,3*, Jingyu Zhao, MSc1,2,3*, Liyun Li1,2,3*, Xiao Yu1,2,3*, Jing Xu1,2,3*, Chun Xu1,2,3*, Yanjie Liu1,2,3*, Weiwei Wang1,2,3*, Zhexiang Kuang1,2,6*, Weiping Yuan1,7 and Jun Shi, MD1,2,3*

1Tianjin Institutes of Health Science, Tianjin, China
2Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
5State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
6State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
7State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Yongrong Lai, MD1*, Rongrong Liu1*, Lijie Wang, PhD2,3*, Xu-Kai Ma, PhD4,5,6*, Yaliang Li, MSc7*, Gaohui Yang1*, Lingling Shi, MD1*, Jia Wei4,5,6*, Zhenbin Wei1*, Xuemei Zhou1*, Kewei Lan2*, Yan Zhang, PhD2*, Xiaodun (Susan) Mou, PhD2*, Li Yang, PhD4,5,6* and Jia Chen, PhD3,8

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2CorrectSequence Therapeutics Co., Ltd, Shanghai, China
3Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai, China
4Center for Molecular Medicine, Children’s Hospital of Fudan University and Shanghai Key Laboratory of Medical Epigenetics, Shanghai, China
5International Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shanghai, China
6Institutes of Biomedical Sciences, Fudan University, Shanghai, China
7CorrectSequence Therapeutics Co., Ltd, Shanghai, AL, China
8Shanghai Clinical Research and Trial Center, Shanghai, China

*signifies non-member of ASH